ResearchClinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy
ResearchChemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity
ResearchClinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement
ResearchIsocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.
ResearchPhase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia
ResearchExpression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues
ResearchIsocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate
ResearchPopulation-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis
ResearchPresentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis
ResearchExtensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia